Can hydroxyzine (Vistaril) cause an increased heart rate (tachycardia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Vistaril Increase Pulse?

Yes, hydroxyzine (Vistaril) can increase heart rate and cause tachycardia, though paradoxically it is also used therapeutically to reduce tachycardia in certain conditions like mast cell activation syndrome.

The Dual Nature of Hydroxyzine and Heart Rate

The relationship between hydroxyzine and heart rate is complex and context-dependent:

Therapeutic Use for Tachycardia Reduction

H1 antihistamines including hydroxyzine are specifically used to reduce histamine-mediated tachycardia in conditions like mast cell activation syndrome (MCAS) and mastocytosis 1, 2. In these settings, hydroxyzine blocks histamine receptors that would otherwise trigger tachycardia, making it a treatment rather than a cause of elevated heart rate.

Documented Cases of Hydroxyzine-Induced Tachycardia

However, hydroxyzine can paradoxically cause tachycardia through different mechanisms:

  • A documented case of supraventricular tachycardia (SVT) occurred in a 9-year-old girl on clinical doses of hydroxyzine, with a heart rate of 250/minute requiring intravenous verapamil for conversion 3. She had three prior palpitation episodes during five months of hydroxyzine use, all resolving after drug discontinuation.

  • Hydroxyzine toxicity in a 13-month-old manifested primarily as sinus tachycardia and seizures 4, demonstrating that excessive doses clearly increase heart rate.

  • In surgical settings, hydroxyzine premedication was associated with sympathetic activation and increased heart rate variability compared to midazolam 5.

Critical Cardiac Safety Concerns

QT Prolongation and Arrhythmia Risk

The FDA drug label explicitly warns that hydroxyzine can cause QT prolongation and Torsade de Pointes (TdP) 6. This is the most serious cardiac concern:

  • Cases of QT prolongation and TdP have been reported in post-marketing surveillance
  • The majority occurred in patients with pre-existing risk factors (heart disease, electrolyte imbalances, concomitant arrhythmogenic drugs)
  • A case report documented hydroxyzine 50 mg triggering TdP in a patient with an ICD, requiring MgSO4, amiodarone, lidocaine, and ultimately sedation/intubation for resolution 7

Anticholinergic Effects

Hydroxyzine has anticholinergic properties that can contribute to tachycardia through muscarinic receptor blockade, similar to atropine-like effects.

Clinical Recommendations

Use hydroxyzine with extreme caution in patients with:

  • Congenital long QT syndrome or family history of long QT
  • Recent myocardial infarction
  • Uncompensated heart failure
  • Bradyarrhythmias
  • Electrolyte imbalances (hypokalemia, hypomagnesemia)
  • Concurrent use of other QT-prolonging medications 6

Monitor for:

  • Baseline and periodic ECGs in at-risk patients
  • Heart rate changes, especially in elderly patients who are more susceptible to anticholinergic effects
  • Electrolyte levels before and during treatment

Avoid in patients with:

  • Clinically significant cardiac disease
  • Known QT interval prolongation
  • Concurrent use of Class IA or III antiarrhythmics, certain antipsychotics, antidepressants, or antibiotics that prolong QT 6

Important Caveats

The 2019 AAAAI guidelines note concern about first-generation antihistamines like hydroxyzine in patients with MCAS who are prone to cardiovascular events 1, despite their therapeutic use for histamine-mediated tachycardia. This reflects the dual-edged nature of the drug.

In elderly patients, start with low doses and observe closely 6, as they are more susceptible to both sedation and cardiovascular effects.

The context matters significantly: hydroxyzine may reduce tachycardia when it's histamine-mediated, but can cause or worsen tachycardia through anticholinergic effects, QT prolongation, or in overdose situations.

Related Questions

Is hydroxyzine approved for infants, and what is the appropriate dosing?
What are the recommended prescribing doses, indications, contraindications, and precautions for hydroxyzine (hydroxyzine hydrochloride) in adults?
Does hydroxyzine (an antihistamine) lower heart rate, specifically in cases of tachycardia?
For how long should a patient who ingested eight Vistaril (hydroxyzine) tablets be observed?
Is hydroxyzine (Vistaril) safe for patients with cardiac disease or a history of heart problems?
What are the differential diagnoses and pertinent questions to ask for a patient presenting with loss of visual field in the left eye?
Can you compare demographic transition theory with logistic growth and define sensitivity, specificity, and positive predictive value, list antenatal non‑communicable disease services, WHO‑recommended iron‑folic acid supplementation duration, investigations at the antenatal booking visit, signs of rat infestation, the meaning and staff of Community‑Based Health Planning Services (CHPS), benefits of school feeding programs, social implications of teenage pregnancy, diseases excluded from NHIS pre‑employment assessment, components of periodic workplace health assessments, health and economic impacts of festivals, and the services a community medical officer should provide (antenatal care, immunizations, family planning, cohort study)?
For a patient who has adverse reactions to Repatha (alirocumab), ezetimibe, and statins, what other lipid‑lowering treatment options are available?
How can iron deficiency be explained in primary polycythemia (polycythemia vera)?
Can vitamin C and methenamine be used to prevent recurrent uncomplicated urinary tract infections in a patient with acidic urine?
Can oral micronized progesterone (e.g., Prometrium) be used as a contraceptive pill, or is it only appropriate for luteal-phase support?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.